TNFSF13 and acute myeloid leukemia: Our study has been the first to have established the concentration of BAFF and APRIL in AML patients, since BAFF and APRIL are not only a transmembrane proteins but it also exist in soluble forms derived from the intracellular cleavage of the full-length protein and confirmed their higher values compared to healthy volunteers.